Volkswagen will pay a 48% premium to buy out the minority shareholders of premium division Audi, Audi said on Tuesday. Volkswagen, which already holds 99.64% of Audi, announced the squeeze-out plans in February. "Volkswagen AG announced and specified that it has set the cash settlement to be paid to the minority shareholders in return for the transfer of their shares at 1,551.53 euros per AUDI AG share," the carmaker said....
Coronavirus vaccine maker Moderna Inc (NASDAQ: MRNA) is closing in on the final stages of its vaccine program and could have the efficacy data by Thanksgiving, paving the way for a potential Emergency Use Authorization approval by the FDA, Bloomberg reported, citing an interview with the company's CEO Stephane Bancel.What Happened: Moderna's coronavirus vaccine, codenamed mRNA-1273, is in Phase 2 testing and could yield efficacy data as early as Thanksgiving if everything goes right, Bancel told Bloomberg. The CEO also discussed about the possibility of the FDA according EUA at high risk."They might decide to give us emergency use approval for people at very high risk, while the agency more carefully reviews the data before granting approval for a broader population, " Bancel said.Moderna is measuring whether the vaccine prevents COVID-19 or potentially prevents infection, she said. Benzinga is covering every angle of how the coronavirus affects the financial world. For...
MARCY-L'ETOILE, France (Reuters) - France's president and top drugmaker announced plans on Tuesday to bolster domestic production of medicines as countries scramble to strengthen their healthcare industries to counter the coronavirus pandemic. Drugmaker Sanofi, which is working on two potential coronavirus vaccines, said it would invest 610 million euros ($679 million) at two French sites to turn them into a hub dedicated to research, development and production of vaccines. Speaking at the Marcy-L'Etoile facility, President Emmanuel Macron also pledged 200 million euros to help domestic research and manufacturing of medicines and said his government would announce plans on Thursday to bring back some drug production facilities to France....
Third Avenue Management recently released its Q1 2020 Investor Letter, a copy of which you can download here. The Third Avenue Real Estate Value Fund posted a return of -28.83% for the quarter as compared to its benchmark, the FTSE EPRA NAREIT Developed Index which returned -28.34% (before fees) in the same quarter. You should […]...
On CNBC's "Mad Money Lightning Round," Jim Cramer said he's concerned about American Tower Corp (NYSE: AMT) because James Taiclet is not running it anymore.Cramer doesn't like Virgin Galactic Holdings Inc (NYSE: SPCE). It has been short-squeezed all the way up and he sees it as too dangerous.He would sell half of the position in Targa Resources Corp (NYSE: TRGP). He doesn't like the stock.Cramer is a seller of Aurora Cannabis Inc (NYSE: ACB).Nikola Corporation (NASDAQ: NKLA) is hot as a pistol and people on Twitter are trying to gun it every day, said Cramer. He needs to do more work on the stock.Cramer would buy Skyworks Solutions Inc (NASDAQ: SWKS) because it has a fabulous 5G chips.He would sell a position in FuelCell Energy Inc (NASDAQ: FCEL) or at least a half of it.See more from Benzinga * Mike Khouw Sees Unusual Options Activity In Barrick Gold * Cramer Weighs...
